Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr 7:10:725-38.
doi: 10.2147/COPD.S77368. eCollection 2015.

A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges

Mario Cazzola  1 , Nicola Alexander Hanania  2 , William MacNee  3 , Katja Rüdell  4 , Claire Hackford  4 , Nihad Tamimi  4
Affiliations
Review

A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges

Mario Cazzola et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Patient-reported outcome (PRO) measures that quantify disease impact have become important measures of outcome in COPD research and treatment. The objective of this literature review was to comprehensively evaluate psychometric properties of available PRO instruments and the ability of each of them to characterize pharmaceutical treatment effects from published clinical trial evidence. Identified in this study were several PRO measures, both those that have been used extensively in COPD clinical trials (St George's Respiratory Questionnaire and Chronic Respiratory Questionnaire) and new instruments whose full value is still to be determined. This suggests a great need for more information about the patient experience of treatment benefit, but this also may pose challenges to researchers, clinicians, and other important stakeholders (eg, regulatory agencies, pharmaceutical companies) who develop new treatment entities and payers (including but not limited to health technology assessment agencies such as the National Institute for Health and Care Excellence and the Canadian Agency for Drugs and Technologies in Health). The purpose of this review is to enable researchers and clinicians to gain a broad overview of PRO measures in COPD by summarizing the value and purpose of these measures and by providing sufficient detail for interested audiences to determine which instrument may be the most suitable for evaluating a particular research purpose.

Keywords: COPD; health related quality of life; patient reported outcome; psychometric properties; quality of life.

PubMed Disclaimer

References

    1. Pocket Guide to COPD Diagnosis, Management, and Prevention [webpage on Internet] Global Initiative for Chronic Obstructive Lung Disease. 2014. [Accessed December 17, 2014]. Available from: http://www.goldcopd.org/guidelines-pocket-guide-to-copd-diagnosis.html.
    1. Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(4):822–832. - PubMed
    1. Centers for Disease Control and Prevention . Morbidity and Mortality Weekly Reports. Atlanta: Centers for Disease Control and Prevention; 2012. [Accessed December 17, 2014]. Available from: http://www.cdc.gov/mmwr/pdf/wk/mm6146.pdf.
    1. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56(11):880–887. - PMC - PubMed
    1. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med. 2007;101(1):146–153. - PubMed

Publication types

MeSH terms